Atherosclerotic plaque development depends on chronic inflammation of the arterial wall. A dysbiotic gut microbiota can cause low-grade inflammation, and microbiota composition was linked to cardiovascular disease risk. However, the role of this environmental factor in atherothrombosis remains undefined. To analyze the impact of gut microbiota on atherothrombosis, we rederived low-density lipoprotein receptor-deficient (Ldlr Ϫ/Ϫ ) mice as germfree (GF) and kept these mice for 16 weeks on an atherogenic high-fat Western diet (HFD) under GF isolator conditions and under conventionally raised specific-pathogen-free conditions (CONV-R). In spite of reduced diversity of the cecal gut microbiome, caused by atherogenic HFD, GF Ldlr Ϫ/Ϫ mice and CONV-R Ldlr Ϫ/Ϫ mice exhibited atherosclerotic lesions of comparable sizes in the common carotid artery. In contrast to HFD-fed mice, showing no difference in total cholesterol levels, CONV-R Ldlr Ϫ/Ϫ mice fed control diet (CD) had significantly reduced total plasma cholesterol, very-lowdensity lipoprotein (VLDL), and LDL levels compared with GF Ldlr Ϫ/Ϫ mice. Myeloid cell counts in blood as well as leukocyte adhesion to the vessel wall at the common carotid artery of GF Ldlr Ϫ/Ϫ mice on HFD were diminished compared to CONV-R Ldlr Ϫ/Ϫ controls. Plasma cytokine profiling revealed reduced levels of the proinflammatory chemokines CCL7 and CXCL1 in GF Ldlr Ϫ/Ϫ mice, whereas the T-cell-related interleukin 9 (IL-9) and IL-27 were elevated. In the atherothrombosis model of ultrasound-induced rupture of the common carotid artery plaque, thrombus area was significantly reduced in GF Ldlr Ϫ/Ϫ mice relative to CONV-R Ldlr Ϫ/Ϫ mice. Ex vivo, this atherothrombotic phenotype was explained by decreased adhesion-dependent platelet activation and thrombus growth of HFD-fed GF Ldlr Ϫ/Ϫ mice on type III collagen. IMPORTANCE Our results demonstrate a functional role for the commensal microbiota in atherothrombosis. In a ferric chloride injury model of the carotid artery, GF C57BL/6J mice had increased occlusion times compared to colonized controls. Interestingly, in late atherosclerosis, HFD-fed GF Ldlr Ϫ/Ϫ mice had reduced plaque rupture-induced thrombus growth in the carotid artery and diminished ex vivo thrombus formation under arterial flow conditions.
covariate. The effect of age was statistically significant (F (1, 32) ϭ 7.002, P ϭ 0.0125). However, there was no significant difference between male and female animals (F (1, 32) ϭ 0.48, P ϭ 0.493) and between CONV-R and GF mice (F (1, 32) ϭ 1.41, P ϭ 0.244) even after adjusting for the effect of age. In conclusion, the age of Ldlr Ϫ/Ϫ mice influenced relative plaque size, but the GF housing condition had no significant influence on late atherosclerotic lesion size in the carotid artery after 16 weeks of HFD feeding.
Germfree Ldlr-deficient mice on HFD show reduced vascular inflammation. To assess the vascular inflammatory phenotype of the generated gnotobiotic mouse model in late atherosclerosis, we next analyzed blood cell counts of GF Ldlr Ϫ/Ϫ mice on HFD relative to CONV-R controls. Feeding on a HFD for 16 weeks increased white blood cell counts in CONV-R Ldlr Ϫ/Ϫ mice relative to GF Ldlr Ϫ/Ϫ mice about 2-fold (Fig. 3A) . The distribution of CD45 ϩ cells revealed that the microbiota-dependent increase in leukocyte counts in CONV-R Ldlr Ϫ/Ϫ mice was most prominent in the myeloid lineage, as shown for monocytes and neutrophils (2-fold increase) ( Fig. 3B and C) . In addition, Values that were significantly different are indicated by bars and asterisks as follows: *, P Ͻ 0.05; **, P Ͻ 0.01. Values that were not significantly different (n.s.) are indicated. (D and E) Correlation between age and the absolute plaque size (in square micrometers) (D) or relative plaque size (as a percentage) (E) at the carotid artery. For all panels, data for CONV-R mice are shown as gray dots, and data for GF animals are shown as white dots. The sex of the mice is color coded as follows: females in red and males in blue. lymphocyte numbers were slightly increased in HFD-fed GF Ldlr Ϫ/Ϫ mice (Fig. 3D ). In contrast, platelet counts were unchanged (not shown). Consistent with the increased myeloid cell numbers, an altered plasma cytokine profile was detected, featuring increased levels of monocyte-derived proinflammatory chemokines CCL7 (chemokine [C-C motif] ligand 7) and neutrophil-derived CXCL1 (chemokine [C-X-C motif] ligand 1) in CONV-R Ldlr Ϫ/Ϫ mice, whereas the T-cell-related interleukins IL-9 and IL-27 were reduced in CONV-R Ldlr Ϫ/Ϫ mice relative to GF Ldlr Ϫ/Ϫ mice (Fig. 3E ). In line with decreased plasma CCL7 and CXCL1 levels and reduced leukocyte counts quantified in the HFD-fed GF Ldlr Ϫ/Ϫ mice compared to HFD-fed CONV-R Ldlr Ϫ/Ϫ mice, intravital imaging of the carotid artery wall demonstrated that the number of adhering leukocytes to the arterial endothelium of HFD-fed GF Ldlr Ϫ/Ϫ mice was significantly reduced relative to CONV-R Ldlr Ϫ/Ϫ controls (Fig. 3F ). Thus, our data indicate that the microbiota enhances vascular inflammation at the carotid artery of HFD-fed Ldlr Ϫ/Ϫ mice.
The microbiota promotes carotid artery thrombosis. The gut microbiota is a factor that promotes ligation injury-induced thrombosis in the carotid artery of C57BL/6J mice on a normal chow diet (12) . Interestingly, in the ferric chloride (FeCl 3 ) injury model of the common carotid artery, GF C57BL/6J mice kept on a CD also For all panels, data for CONV-R mice are shown in gray, and data for GF animals are shown in white. For panels A to D, the sex of the mice is color coded as follows: females in red and males in blue.
showed reduced thrombus growth compared to CONV-R C57BL/6J controls, as shown by significantly prolonged occlusion times (846.7 Ϯ 54.5 s in GF mice relative to 635.1 Ϯ 43.8 s in CONV-R mice) ( Fig. 4A ). Likewise, also ex-GF mice that were colonized for 14 days with a cecal gut microbiota from a CONV-R donor mouse (conventionally derived) presented significantly reduced occlusion times (639.6 Ϯ 64.5 s) compared to GF mice (846.7 Ϯ 54.5 s) (data not shown). Our experimental data on GF wild-type C57BL/6J mice indicate that the microbiota promotes arterial thrombus growth, but whether the microbiota also supports thrombus growth in atherothrombosis, where subendothelial matrix components from the ruptured atherosclerotic plaque come into contact with platelets, is currently unknown.
To assess whether the influence of the gut microbiota on platelet reactivity (11, 21) impacts atherosclerotic plaque thrombogenicity in vivo, we applied an established ultrasound-induced plaque rupture model of the carotid artery plaque, resulting in local collagen exposure (33, 34) . Importantly, we found that following ultrasound-induced plaque rupture, thrombus growth was reduced by approximately 60% in GF mice compared to CONV-R Ldlr Ϫ/Ϫ mice on a HFD ( Fig. 4B ). Collectively, our intravital imaging results demonstrate that the presence of gut microbiota enhances ferric chloride-induced carotid artery thrombosis in C57BL/6J mice on a CD and plaque rupture-induced thrombus growth at the carotid artery plaque of late atherosclerotic Ldlr Ϫ/Ϫ mice.
The microbiota promotes adhesion-induced platelet activation in Ldlr-deficient mice receiving HFD. As collagen is the major platelet-activating constituent of atherosclerotic plaques (35, 36) , we wanted to pinpoint whether platelet adhesion of HFD-fed GF Ldlr Ϫ/Ϫ mice to collagen is reduced compared with HFD-fed CONV-R Ldlr Ϫ/Ϫ mice. For this purpose, we used an ex vivo microspot-based flow chamber model, allowing multiparameter assessment of thrombus formation upon whole-blood perfusion over collagen type I and type III coatings, resulting in precise characterization of the thrombotic process and the relevant platelet activation markers (37) ( Fig. 5 ; Fig. S5 ). Indeed, supporting the reduced thrombus growth in vivo, in this model of arterial flow-dependent thrombus formation in anticoagulated whole blood, HFD-fed GF mice showed a reduced phosphatidylserine (PS)-positive surface area coverage on type I and type III collagen compared to the blood of HFD-fed CONV-R Ldlr Ϫ/Ϫ mice ( Fig. 5A to D). On type III collagen, a reduced thrombus contraction score, multilayer score, and thrombus height were observed ( Fig. 5C and E). Other parameters of platelet adherence to type I and type III collagen, such as platelet deposition, morphological score, and P-selectin surface area coverage were unchanged in this model ( Fig. 5A and could affect the progression of atherosclerosis and subsequent atherothrombosis. Feeding Ldlr Ϫ/Ϫ mice atherogenic HFD for 16 weeks resulted in a significantly reduced diversity of the cecal gut microbiota compared to feeding mice CD. In accordance with previous reports, this resulted in a decrease of the Bacteroidetes phylum and an increase in Firmicutes in the HFD group compared with littermate controls kept on a CD (38, 39) . Importantly, HFD feeding was linked to changes in the gut microbiota associated with impaired intestinal barrier function and increased gut microbiota-dependent metabolic endotoxemia (31) .
Total plasma cholesterol, VLDL, LDL, and HDL cholesterol levels were unchanged in CONV-R Ldlr Ϫ/Ϫ mice compared to GF Ldlr Ϫ/Ϫ mice after 16 weeks of HFD. Likewise, GF and CONV-R HFD-fed Ldlr Ϫ/Ϫ mice, receiving the same HFD for 2 weeks, did not show differences in total cholesterol levels (40) . However, with basal CD feeding conditions, the absence of commensal microbiota evoked a striking increase in plasma cholesterol levels in the GF Ldlr Ϫ/Ϫ mice. Our data therefore indicate a spill-over of cholesterol resulting from the HFD feeding, which may mask the bacterial effect. Our results on increased plasma cholesterol levels in GF Ldlr Ϫ/Ϫ mice relative to CONV-R Ldlr Ϫ/Ϫ mice fed CD are in accordance with a number of reports on increased free cholesterol levels, as well as an increase in the concentration of cholesterol esters in GF Apoe Ϫ/Ϫ C57BL/6J mice (7, 28, 41) . Thereby, our results demonstrate that the cholesterol-lowering effect of the gut microbiota is not specific to the Apoe Ϫ/Ϫ hyperlipidemia mouse model. This could be due to enhanced microbiota-dependent cholesterol synthesis and reduced bile acid synthesis (41) . Indeed, it is most likely that the microbiota-dependent conversion of primary to secondary bile acids plays a central role under steady-state conditions (42) . The involvement of the gut microbiome in the regulation of cholesterol levels is further substantiated by a clinical study demonstrating that several bacterial taxa correlated with plasma cholesterol levels in atherosclerotic patients (8) . Based on our findings, it will be interesting to dissect which specific members of the microbiota promote cholesterol excretion and how their relative abundance can be modulated through targeted dietary or probiotic intervention strategies. Coherent with previous studies on GF Apoe Ϫ/Ϫ mice kept on hypercholesterolemic diet (7, 18, 28) , we found the absolute size of late atherosclerotic plaques in the carotid artery unchanged between HFD-fed GF Ldlr Ϫ/Ϫ mice and HFD-fed CONV-R Ldlr Ϫ/Ϫ mice. Therefore, it will be interesting to analyze in future work whether the microbiota modulates early atherosclerosis. Moreover, the commensal microbiota is composed of both pathogenic and protective bacteria, which could also explain why the absence of microbiota did not yield in significant changes in the atherosclerotic lesion size.
Although the absolute size of the carotid artery lesions was not affected, we observed signs of elevated low-grade inflammation in CONV-R Ldlr Ϫ/Ϫ mice compared to GF Ldlr Ϫ/Ϫ mice fed HFD. This was indicated by increased white blood cell counts, namely, neutrophils and monocytes, along with elevated plasma CCL7 and CXCL1 levels. In accordance, both CCL7 and its receptor CCR2, as well as CXCL1 have been implicated in monocyte mobilization from the bone marrow in steady state and under conditions of hyperlipidemia, respectively (43, 44) . Nevertheless, this did not result in increased lesional macrophage content in plaques of mice receiving 16 weeks of a HFD. Furthermore, increased levels of T-cell-related IL-9 and IL-27 were detected in the plasma of GF Ldlr Ϫ/Ϫ mice. In the Ldlr Ϫ/Ϫ mouse model, IL-27 had an inhibitory role on atherogenesis as it inhibited bone marrow-derived cell activation in the arterial walls (45) . In contrast, IL-9 was functionally linked to aggravated atherosclerosis in Apoe Ϫ/Ϫ mice by the induction of vascular cell adhesion molecule 1 expression (46) . In line with elevated myeloid blood cell counts, enhanced vascular inflammation was apparent by intravital imaging of the luminal side of carotid artery plaques prior to ultrasoundinduced rupture, with substantially increased leukocyte accumulation. Interestingly, in the Apoe Ϫ/Ϫ mouse atherosclerosis model, this vascular inflammatory phenotype in the atheroma-prone regions of the carotid artery was demonstrated to depend on the endothelial expression of the Notch effector recombination signal binding for immunoglobulin kappa J region (RBPJ) (47), but the microbiota-dependent impact on endothelial pathways promoting leukocyte adhesion in atherosclerosis needs further investigation.
To investigate the impact of the gut microbiota in atherothrombosis, we exploited ultrasound-induced carotid artery plaque rupture combined with intravital imaging of thrombus growth (33) . Our data revealed a marked reduction in thrombus size in the HFD-fed GF Ldlr Ϫ/Ϫ mice compared with their HFD-fed CONV-R Ldlr Ϫ/Ϫ counterparts, pointing to a stimulatory effect of the gut microbiota on experimental atherothrombosis. This finding expands on previous work from our laboratory, demonstrating that the presence of commensals promotes arterial thrombus growth in the ligation-injured carotid artery (12) . The role of the gut microbiota in arterial thrombosis is further corroborated by our data with the carotid artery ferric chloride injury model, showing a significantly prolonged time course of thrombus growth in GF C57BL/6J mice relative to CONV-R wild-type controls. To mimic physiological arterial flow conditions, we analyzed thrombus formation on collagen type I and type III, the major plateletactivating matrix constituents of carotid artery plaques (35) , with a sensitive standardized whole-blood flow chamber system to detect differences in thrombus growth and adhesion-dependent platelet activation (37) . Similar to our in vivo observations, we found reduced thrombus height, contraction score, and multilayer score of thrombi formed on type III collagen in the anticoagulated whole blood from HFD-fed GF Ldlr Ϫ/Ϫ mice compared to HFD-fed CONV-R Ldlr Ϫ/Ϫ mice. Exposure of phosphatidylserine was likewise decreased on collagen type I and type III coatings, which is known to be mediated via signaling of the collagen receptor glycoprotein VI (GPVI) (36, 48) , a crucial receptor for platelet adhesion and aggregate formation at the arterial injury site (49) (50) (51) . Since we uncovered a microbiota-dependent increase in adhesion-induced platelet activation, it will be most interesting to study platelet GPVI signaling related to phosphatidylserine exposure in the GF hyperlipidemic Ldlr Ϫ/Ϫ mouse model.
In conclusion, our data demonstrate that the microbiota does not modulate late absolute atherosclerotic lesion size in the carotid artery, thus supporting recent reports using the Apoe Ϫ/Ϫ mouse model (7, 18, 28) . Here we confirmed in the Ldlr Ϫ/Ϫ mouse hypercholesterolemia model that the gut microbiota reduces plasma cholesterol levels with CD feeding, but not under HFD-induced hypercholesterolemia in the Ldlr Ϫ/Ϫ mouse model (7, 28) . Our results demonstrate that, despite not affecting the absolute lesion area in the carotid artery, the commensal microbiota augments low-grade inflammation in the vessel wall. Our results suggest that a diminished adhesiondependent platelet activation on type I and type III collagen causes reduced plaque rupture atherothrombosis in the carotid artery of HFD-fed GF Ldlr Ϫ/Ϫ mice. Future experiments should provide mechanistic insights on how the gut microbiota interferes with platelet-collagen interaction, the pivotal pathomechanism in arterial thrombosis.
MATERIALS AND METHODS
Animals. B6.129S7Ldlrtm1Her/J mice (Ldlr Ϫ/Ϫ mice) (52) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Ldlr Ϫ/Ϫ mice were rederived as germfree (GF) by aseptic hysterectomy and maintained as a GF mouse colony in sterile flexible film mouse isolator systems. The germfree status of mice was tested weekly by PCR for detection of 16S rDNA and by bacterial culture. All experimental animals were 9-to 29-week-old male or female mice housed in the Translational Animal Research Center (TARC) of the University Medical Center Mainz under specific-pathogen-free (SPF, CONV-R) or GF conditions in EU type II cages with two to five cage companions with standard autoclaved lab diet and water ad libitum, 22°C Ϯ 2°C room temperature, and a 12-h light/dark cycle. All groups of mice were sex and age matched, and all mice were free of clinical symptoms. All procedures performed on mice were approved by the local committee on legislation on protection of animals (Landesuntersuchungsamt Rheinland-Pfalz, Koblenz, Germany; 23177-07/G12-1-100; 23177-07/G13-1-072, 23177-07/G16-1-013, and 23 177-07/A 18-1-005 OEW). paired-end assembled, and mapped onto the different samples using the barcode information. Sequences were assigned to operational taxonomic units (OTUs) using uclust and the greengenes reference database (gg_13_8 release) with 97% identity. Representative OTUs were picked and taxonomy assigned using uclust and the greengenes database. Quality filtering was performed by removing chimeric sequences using ChimeraSlayer and by removing singletons and sequences that failed to align with PyNAST. The reference phylogenetic tree was constructed using FastTree 2. All samples within a single analysis were normalized by rarefaction to the minimum shared read count to account for differential sequencing depth among samples (95,000 sequences per sample). Relative abundance was calculated by dividing the number of reads for an OTU by the total number of sequences in the sample. Alpha diversity measures were computed, and unweighted Unifrac beta diversity was calculated and visualized by principal coordinate analysis. Significance of differences in abundances of various taxonomic units between control (CD) and HFD groups was calculated using t test, and P values were adjusted for multiple testing using false-discovery rate (FDR) correction (q-value). Linear discriminant analysis (LDA) effect size (LEfSe) was performed using the online tool available at http://huttenhower.sph.harvard.edu/ galaxy/. Lipoprotein profile analysis. Plasma samples were subjected to fast-performance liquid chromatography (gel filtration on Superose 6 column; GE Healthcare). Different lipoprotein fractions were separated and evaluated based on flowthrough time. Cholesterol levels were quantified using an enzymatic assay (Cobas, Roche) according to the manufacturer's protocol.
Analysis of carotid artery atherosclerotic lesion using histology. Lesion development in the left common carotid artery was quantified by hematoxylin-and-eosin (H&E) staining of 4-m longitudinal cryosections.
Hematologic analysis. EDTA anticoagulated mouse whole blood was collected from anesthetized mice (5 mg/kg midazolam [5 mg of midazolam per kg of body weight], 0.5 mg/kg medetomidine, 0.05 mg/kg fentanyl), by intracardial puncture. Platelet and total and differential white blood cell counts were determined using an automatic cell counter (ADVIA; Siemens, Erlangen, Germany).
Flow cytometry. Whole blood was collected in an EDTA-buffered tube, subjected to red blood cell lysis, and centrifuged for 5 min at 300 ϫ g, and cell pellets were subsequently stained with different antibody cocktails for analysis by flow cytometry. Flow cytometry was conducted with a FACS Canto II, using FACSDiva software (BD Biosciences). Cell populations were discriminated by the following antibody cocktail: anti-CD45 (clone 30-F11; eBioscience), anti-CD115 (clone AFS98; eBioscience), anti-Gr1 (clone RB6-8C5; Biolegend), anti-CD11b (clone M1/70; eBioscience), anti-B220 (clone RA3-6B2; eBioscience), and anti-CD3 (clone 145-2C11; eBioscience). Cell populations and marker expression were gated using the FlowJo analysis program (Treestar): leukocytes (CD45 ϩ ), neutrophils (CD45 ϩ CD115-Gr1 high ), monocytes (CD45 ϩ CD11b ϩ CD115 ϩ ), and lymphocytes (CD45 ϩ CD3 ϩ and CD45 ϩ B220 ϩ ).
Cytokine analysis. Cytokine levels in mouse plasma samples were measured using the ProcartaPlex Multiplex Immunoassay technology from Affymetrix (Affymetrix, eBioscience, ProcartaPlex Mouse Cytokine & Chemokine Panel 1, 26-plex), according to the manufacturer's protocol.
Preparation of platelets and leukocytes for intravital epifluorescence microscopy. Mice were anesthetized by intraperitoneal injection of a solution of midazolame (5 mg/kg body weight), medetomidine (0.5 mg/kg body weight), and fentanyl (0.05 mg/kg body weight). Citrated whole blood was collected by intracardial puncture. Murine platelets were isolated and labeled with Rhodamin B (20 g/ ml). The labeled platelet suspension was adjusted to a final concentration of 150 ϫ 10 3 platelets/l, and 250 l of suspension was injected via a jugular vein catheter. Thrombus formation of murine platelets was assessed by high-speed epifluorescence microscopy 10 min after plaque rupture. To characterize leukocyte adhesion and rolling in vivo, leukocytes stained with acridine orange (50 g/l; 100 l per mouse; Sigma-Aldrich) were imaged.
Mouse common carotid artery thrombosis models. Plaque rupture and measurement of acute thrombus formation were performed as described earlier (33) . Ldlr Ϫ/Ϫ mice were fed high-fat diet with 42% from fat for 16 weeks. After the mice were anesthetized by intraperitoneal injection of a solution of midazolame (5 mg/kg; Ratiopharm GmbH, Ulm, Germany), medetomidine (0.5 mg/kg; Pfizer Deutschland GmbH, Berlin, Germany), and fentanyl (0.05 mg/kg; Janssen-Cilag GmbH, Neuss, Germany), a polyethylene catheter (0.28-mm inner diameter [ID], 0.61-mm outer diameter [OD]; Smiths Medical Deutschland GmbH, Grasbrunn, Germany) was implanted into the right jugular vein, and the right carotid artery was dissected free from surrounding tissue. The animal was injected intravenously with Rhodamin B-labeled platelets obtained from a donor mouse with the same genetic background, hygiene status, and feeding procedure. A subset of mice were also injected with acridine orange for leukocyte staining.
The ferric chloride injury model was performed by placing a 1-mm 2 filter paper that was soaked with 10% (wt/wt) FeCl 3 solution for 3 min laterally to the common carotid artery (55) . Prior to the ferric chloride injury, the anesthetized mouse was infused with 5-(and 6-) carboxy-2=,7=-dichlorofluorescein diacetate (DCF)-stained platelets (green), as previously described (12) . Directly after 3 min, the filter paper and any residuals were flushed away with isotonic sodium chloride solution that was warmed to 37°C. Then, the common carotid artery of the mouse was placed under the objective, and the resulting thrombus formation was recorded until the artery was completely occluded by using a high-speed wide-field Olympus BX51WI fluorescence microscope with a long-distance condenser and a 10ϫ (numerical aperture [NA] of 0.3) water immersion objective with a monochromator (MT 20E; Olympus Deutschland GmbH, Hamburg, Germany) and a charge-coupled-device camera (ORCA-R2; Hamamatsu Photonics, Japan). The time to occlusion of the FeCl 3 -injured common carotid artery was determined. If the carotid artery did not occlude within 45 min, the experiment was terminated. Videos were recorded before the application of the filter paper, directly after removing the filter paper, and then at 3-min intervals.
Intravital high-speed video epifluorescence microscopy. Using intravital fluorescence microscopy, a plaque was selected, and a rupture was induced by ultrasound application using a VibraCell VCX130 processor (Sonics, Newtown, CT, USA) (33, 34) . Measurements were performed with a high-speed wide-field Olympus BX51WI fluorescence microscope using a long-distance condenser and a 10ϫ (NA of 0.3) water immersion objective with a monochromator (MT 20E; Olympus Deutschland GmbH, Hamburg, Germany) and a charge-coupled-device camera (ORCA-R2; Hamamatsu Photonics, Japan). For image acquisition and analysis, the Realtime Imaging System eXcellence RT (Olympus Deutschland GmbH, Hamburg, Germany) software was used. Thrombus formation was recorded as soon as possible by capturing fluorescent images for at least 10 min. For image analysis, a threshold level was set, and thrombus area was measured.
Whole-blood thrombus formation and platelet adhesion under flow. Experiments were performed as described previously (56) with minor modifications. Glass coverslips (24 by 60 mm) were coated with two microspots (0.5 l/spot) in the direction of the flow: (i) collagen type III (100 g/ml; Octapharma, Berlin, Germany) and (ii) collagen type I (100 g/ml; Nycomed Pharma, Munich, Germany). The coated coverslips were blocked with modified Tyrode's HEPES buffer (pH 7.45) (TH buffer) (5 mM HEPES, 136 mM NaCl, 2.7 mM KCl, 2 mM MgCl 2 , 0.42 mM NaH 2 PO 4 ) containing 1% bovine serum albumin (BSA) and mounted in parallel plate flow chambers.
Blood samples were collected by retro-orbital puncture of mice under isoflurane anesthesia into 40 M PPACK, 5 U/ml heparin, and 50 U/ml fragmin (final concentrations) and perfused for 3.5 min, at a wall shear rate of 1,000 s Ϫ1 , over the microspot coatings. The platelets were stained by 2 min after perfusion with Tyrode's HEPES buffer (pH 7.45) (5 mM HEPES, 136 NaCl, 2.7 mM KCl, 2 mM MgCl 2 , 0.42 NaH 2 PO 4 , 2 mM CaCl 2 , 1 mg/ml glucose, 1 U/ml heparin, and 1 mg/ml BSA), supplemented with fluorescein isothiocyanate (FITC)-labeled rat anti-mouse CD62P monoclonal antibody (MAb) (1:40) (Emfret Analytics, Würzburg, Germany), phycoerythrin (PE)-labeled rat anti-mouse JON/A MAb (1:20) (Emfret Analytics), and Alexa Fluor 647 (AF647)-labeled annexin A5 (1:200) (Invitrogen Life Technologies, Carlsbad, CA, USA). Representative end-stage bright-field microscopic images were taken from each microspot during staining. After 2 min of stasis, remaining labels were washed away by perfusion with label-free Tyrode's HEPES buffer, after which three representative end-stage fluorescence images were collected per microspot.
Microscopic images (1,360 by 1,024 pixels, 142 by 107 m, 8-bit) were recorded with an EVOS fluorescence microscope (Life Technologies, Carlsbad, CA, USA), equipped with green fluorescent protein (GFP), red fluorescent protein (RFP), and Cy5 light-emitting diode (LED) cubes, and an Olympus 60ϫ oil immersion objective, basically as described previously (37) . Recorded images were analyzed using semiautomated scripts written in Fiji software (Laboratory for Optical and Computational Instrumentation at the University of Wisconsin-Madison, USA). This resulted in percentages of surface area coverage (%SAC) of deposited platelets/thrombus (from bright-field images) and of %SAC of platelet/thrombus fluorescence per fluorescent label. In addition, bright-field images were analyzed for a morphological score (scale of 0 to 5), thrombus contraction score (scale of 0 to 3), and thrombus height (multilayer, scale of 0 to 3) in comparison to reference images, to provide an indication of the overall size and height of platelet aggregates on the microspots (37) . Finally, the %SAC of multilayered thrombi was analyzed by manual coloring in Fiji.
For each flow run, parameter values from individual bright-field and fluorescence images were averaged to obtain one value per parameter per microspot. These values were linearly normalized to a scale from 0 to 10 per individual parameter. Gene effect heatmaps were obtained by subtracting the normalized average values per parameter of GF mice minus CONV-R mice. Differences compared to CONV-R mice were considered statistically significant with P Ͻ 0.05 (t test, two-sided, equal variance) after correction for multiple comparisons, where required. Subtraction heatmaps were produced by using the R package version 3.2.5 (www.r-project.org).
Statistical analysis. Data are presented as means Ϯ standard errors of the means (SEM). Statistical calculations were performed with GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA) using the independent samples Student's t test to compare two groups and analysis of variance (ANOVA) with Tukey post hoc test for more than two groups.
Availability of data and materials. Sequence files and metadata for all samples used in this study have been deposited in the ENA database (https://www.ebi.ac.uk/ena) under the accession numbers ERS2865886 to ERS2865897. The applied commands and the LDA effect size are provided as supplemental material (Text S1). Other data sets used and/or analyzed during the current study are available from the corresponding author upon request.
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